[1]万娟,吴亚姗,杨力强.方剂配伍实验研究概况[J].西部中医药,2022,35(06):153-157.[doi:10.12174/j.issn.2096-9600.2022.06.38]
 WAN Juan,WU Yashan,YANG Liqiang.The General Situation of Experimental Researches on the Compatibility of Formulations[J].Western Journal of Traditional Chinese Medicine,2022,35(06):153-157.[doi:10.12174/j.issn.2096-9600.2022.06.38]
点击复制

方剂配伍实验研究概况
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年06期
页码:
153-157
栏目:
研究进展
出版日期:
2022-06-15

文章信息/Info

Title:
The General Situation of Experimental Researches on the Compatibility of Formulations
作者:
万娟, 吴亚姗, 杨力强
广西中医药大学,广西 南宁 530200
Author(s):
WAN Juan, WU Yashan, YANG Liqiang
Guangxi University of Chinese Medicine, Nanning 530200, China
关键词:
方剂配伍实验研究
Keywords:
prescriptioncompatibilityexperimental research
分类号:
R289
DOI:
10.12174/j.issn.2096-9600.2022.06.38
文献标志码:
A
摘要:
从药效物质基础研究、中药复方药代动力学研究、作用机制研究、拆方研究和方剂有效组分配伍研究等方面小结近年来关于方剂配伍的实验研究情况,并对其未来研究的趋势进行展望。
Abstract:
Experimental research into the compatibility of the formulations in the recent years is summa-rized from basic research on pharmacodynamic substances, study on pharmacokinetics of Chinese herbal compound, mechanism study, decomposed prescription and study on the compatibility and the active ingredients of the formulation, meanwhile, to prospect the trend of its future studies.

相似文献/References:

[1]杨志军,李初谊,郭胜△,等.当归及不同配伍对环磷酰胺诱导的小鼠免疫器官、吞噬功能的影响[J].西部中医药,2013,26(04):8.
 YANG Zhijun,LI Chuyi,GUO Sheng,et al.Influence of DangGui and Its Compatibility on Immune Organs and Phagocytic Function of Mice Induced by Cyclophosphamide[J].Western Journal of Traditional Chinese Medicine,2013,26(06):8.
[2]杨洁.浅谈姜制法与姜的药对配伍[J].西部中医药,2013,26(04):12.
 YANG Jie.On Ginger Processing Method and Couplet Medicine Compatibility of Ginger[J].Western Journal of Traditional Chinese Medicine,2013,26(06):12.
[3]赵洁,戴慎△.金元时期补阳、补气方剂配伍规则探析[J].西部中医药,2015,28(12):12.
[4]卢振方,叶品良,沈涛△.试论中医方剂中的相对剂量与绝对剂量[J].西部中医药,2015,28(11):10.
[5]杨宏权,谢嫱察草△,久仙加.浅谈藏药的炮制与剂型[J].西部中医药,2012,25(05):45.
 YANG Hong-quan,XIE QIANG Cha-cao,JIU Xian-jia.On Preparation and Processing of Tibetan drugs[J].Western Journal of Traditional Chinese Medicine,2012,25(06):45.
[6]罗林云.李可中医药学术流派附子半夏配伍临床应用特点[J].西部中医药,2017,30(04):70.
 LUO Linyun.Discussion on Clinical Application Features of FuZi Compatible with BanXia Based on LI Ke′s Academic School of Chinese Medicine[J].Western Journal of Traditional Chinese Medicine,2017,30(06):70.
[7]张民,李秀娟,徐思羽,等.血塞通注射液与常用抗菌药物配伍的稳定性考察[J].西部中医药,2018,31(08):7.
 ZHANG Min,LI Xiujuan,XU Siyu,et al.Investigation into the Stability of Compatibility between XueSaiTong Injection and Commonly-used Antibacterials[J].Western Journal of Traditional Chinese Medicine,2018,31(06):7.
[8]王道坤.中医辨证应用毒性药物的安全性探讨[J].西部中医药,2022,35(06):44.[doi:10.12174/j.issn.2096-9600.2022.06.12]
 WANG Daokun.The Safety of Toxic Drugs in TCM Syndrome Differentiation[J].Western Journal of Traditional Chinese Medicine,2022,35(06):44.[doi:10.12174/j.issn.2096-9600.2022.06.12]
[9]陈春光,倪建俐.基于数据分析当代名老中医治疗胃脘痛的用药规律[J].西部中医药,2022,35(06):86.[doi:10.12174/j.issn.2096-9600.2022.06.22]
 CHEN Chunguang,NI Jianli.Contemporary Famous TCM Doctors′ Medication Laws of Treating Epigastric Pain Based on Data Mining[J].Western Journal of Traditional Chinese Medicine,2022,35(06):86.[doi:10.12174/j.issn.2096-9600.2022.06.22]
[10]王一迪,唐尊昊,曲夷.经方中细辛配伍应用规律研究[J].西部中医药,2021,34(10):94.[doi:10.12174/j.issn.2096-9600.2021.10.23]
 WANG Yidi,TANG Zunhao,QU Yi.Application Law of the Compatibility of Xixin in Classical Prescription[J].Western Journal of Traditional Chinese Medicine,2021,34(06):94.[doi:10.12174/j.issn.2096-9600.2021.10.23]
[11]邱建智.藏药学基础理论与方剂配伍规律的探析[J].西部中医药,2013,26(01):64.
 QIU Jianzhi.Probing into Theoretical Foundation and Prescription Compatibility Rules of Tibetan Medicine[J].Western Journal of Traditional Chinese Medicine,2013,26(06):64.
[12]陈静,格桑顿珠,索朗次仁,等.藏药复方八味獐芽菜的性味、配伍研究[J].西部中医药,2019,32(02):70.
 CHEN Jing,GESANG Dunzhu,SUOLANG Ciren,et al.Study on the Property and Flavor, Compatibility of Tibetan Medicine Compound BaWei ZhangYaCai[J].Western Journal of Traditional Chinese Medicine,2019,32(06):70.

备注/Memo

备注/Memo:
万娟(1993—),女,在读硕士研究生。研究方向:方剂配伍规律文献、临床及作用机理研究。国家自然科学基金(81560748);广西自然科学基金(2018GXNSFAA050079);广西教育厅重点项目(KY2015ZD059)。
更新日期/Last Update: 2022-06-24